Genomics Inform Search


Genomics Inform > Volume 12(4); 2014 > Article
Jeong, Chung, Park, Cho, and Hong: Genome-Wide Association Study of Metabolic Syndrome in Koreans


Metabolic syndrome (METS) is a disorder of energy utilization and storage and increases the risk of developing cardiovascular disease and diabetes. To identify the genetic risk factors of METS, we carried out a genome-wide association study (GWAS) for 2,657 cases and 5,917 controls in Korean populations. As a result, we could identify 2 single nucleotide polymorphisms (SNPs) with genome-wide significance level p-values (<5 × 10-8), 8 SNPs with genome-wide suggestive p-values (5 × 10-8 ≤ p < 1 × 10-5), and 2 SNPs of more functional variants with borderline p-values (5 × 10-5 ≤ p < 1 × 10-4). On the other hand, the multiple correction criteria of conventional GWASs exclude false-positive loci, but simultaneously, they discard many true-positive loci. To reconsider the discarded true-positive loci, we attempted to include the functional variants (nonsynonymous SNPs [nsSNPs] and expression quantitative trait loci [eQTL]) among the top 5,000 SNPs based on the proportion of phenotypic variance explained by genotypic variance. In total, 159 eQTLs and 18 nsSNPs were presented in the top 5,000 SNPs. Although they should be replicated in other independent populations, 6 eQTLs and 2 nsSNP loci were located in the molecular pathways of LPL, APOA5, and CHRM2, which were the significant or suggestive loci in the METS GWAS. Conclusively, our approach using the conventional GWAS, reconsidering functional variants and pathway-based interpretation, suggests a useful method to understand the GWAS results of complex traits and can be expanded in other genomewide association studies.


Metabolic syndrome (METS) is a disorder of energy utilization and storage and increases the risk of developing cardiovascular disease and diabetes. METS includes multiple clinical traits, as follows: increased plasma glucose, abdominal obesity, dyslipidemia, and high blood pressure [1]. METS is a great concern in developing countries, because the prevalence of METS is gradually increasing, especially in countries where it follows obesity trends, sedentary lifestyle, and high consumption of calories [2, 3, 4]. A Korean twin study showed that the METS has 51%-60% heritability, indicating a significant role of genetic factors in the development of METS [5]. Therefore, understanding the genetic factors underlying the syndrome and their correlation is clinically important.
Recent advances in high-throughput genomics technologies have allowed massive testing of genetic variants in minimal time [6, 7]. The reductions in cost and time have made it feasible to conduct large-scale genome-wide association studies (GWASs) that genotype many thousands of single nucleotide polymorphisms (SNPs) in thousands of individuals. So far, approximately 1,900 reports with 13,000 SNPs (GWAS catalog; Apr 14, 2014) have been published to identify the gene-disease or -non-disease trait associations. The quantitative traits related to METS have already been studied by the conventional GWAS in the Korean population [8], but there is no Korean GWAS report about METS cases and controls.
On the other hand, relatively little trait heritability can be explained by the conventional GWAS [9]. These phenomena, called missing heritability problems, are hard to solve by conventional GWAS, in part because of the extensive multiple testing correction in GWAS analysis, low effect size of common variants, and the difficulty of detecting low-frequency or rare variants in conventional GWAS. Multiple testing correction is necessary to exclude false-positive loci, but simultaneously, it discards many true-positive loci [10]. Also, most SNPs in these GWASs lie in intergenic and intron regions and do not appear to affect protein sequence. Thus, these SNPs are likely functionally neutral or just proxies of causal variants located in the same linkage disequilibrium (LD). To understand the amount of true-positive signals in the discarded association results, we computed the proportion [V(G)/V(P)] of the phenotypic variance [V(P)] that is explained by the genotype variance [V(G)] using the significant and discarded SNP results [11].
Recently, Fransen et al. [10] reported a GWAS using expression quantitative trait loci (eQTL) information. They selected eQTL among the GWAS results for Crohn's disease and conducted follow-up replication studies [10]. They showed that eQTL-based pre-selection for follow-up is a useful approach for identifying risk loci from a moderately sized GWAS.
Based on previous knowledge, we applied an alternative analysis strategy to understand the genetic components of METS. First of all, we conducted a conventional GWAS for METS cases and healthy controls to discover the top significant signals. Thereafter, we tried to uncover the functional variants, such as nonsynonymous SNPs (nsSNPs) and eQTLs, among the SNPs to be discarded using the stringent criteria of the conventional GWAS. Finally, we drew a pathway of the significantly associated GWAS SNPs and the remaining less significantly associated functional SNPs. The overall study design is schematically described in Supplementary Fig. 1.


Study subjects

The study subjects were originally derived from a part of the Korean Genome and Epidemiology Study (KoGES) project, which was the national project to establish genome epidemiology cohorts of Korean dwellers or immigrants/emigrants [12]. Among the KoGES cohorts, the Korean Association Resource Consortium (KARE) has established a public GWAS dataset by using the Ansan-Anseong cohort, which is an ongoing biennially followed-up cohort in the KoGES [13]. The KARE dataset consists of the individual SNP chip genotypes and the epidemiological/clinical phenotypes for studying the genetic components of Korean public health. Written informed consent was obtained from all participants at the KoGES, and this research project was approved by the Institutional Review Board of Korea National Institute of Health (KNIH). The obtained KARE dataset passed the quality control criteria and was reported in previous GWAS reports [8, 13]. Briefly, the subjects with genotype accuracies below 98% and high missing genotype call rates (≥5%), high heterozygosity (>30%), or inconsistency in sex were excluded from subsequent analysis. Individuals who had a tumor were excluded, as were related individuals whose estimated identity-by-state values were high (>0.80). Based on these criteria, 8,842 samples were selected; these quality control steps have been described in a previous GWAS [13].

Study phenotypes and covariates

We used the general information on resident areas (Anseong or Ansan), sex, and age as the covariates and past disease history of diabetes, hypertension, and lipidemia as exclusion criteria for non-METS healthy controls. The height and body weight were used to calculate the body mass index (BMI) as another covariate, and waist circumference (WC), systolic and diastolic blood pressures (SBP and DBP), fasting plasma glucose levels (GLU0), high-density lipoprotein (HDL) cholesterol, and triglyceride (TG) were used to diagnose METS. METS was defined by the presence of three or more of the following five components according to the NCEP-ATPIII criteria using WC for Asians [14, 15]: WC (≥90 cm for men and ≥80 cm for women), HDL (<40 mg/dL for men, <50 mg/dL for women), TG (≥150 mg/dL), SBP (≥130 mm Hg) and/or DBP (≥85 mm Hg), and GLU0 (≥100 mg/dL).

Study genotypes

The genotyping of the cohort population was previously described for the KARE study [16]. Most DNA samples were isolated from the peripheral blood of participants and genotyped using Affymetrix Genomewide Human SNP array 5.0 (Affymetrix, Inc., Santa Clara, CA, USA). The quality control steps of the genotypes have been described elsewhere [13]. Briefly, the calling of the genotyping was determined by Bayesian Robust Linear Modeling using the Mahalanobis Distance genotyping algorithm [17]. Consequently, 352,227 SNPs had a missing genotype call rate below 0.1, a minor allele frequency greater than 0.01, and no deviation from Hardy-Weinberg equilibrium (p > 1 × 10-6). Additionally, the previous GWAS reported no population stratification between the Anseong and Ansan cohorts [13].

Statistical analysis

The GWAS for METS cases and controls was conducted by logistic regression analysis, adjusting for residential area, sex, age, and BMI as covariates, implemented in PLINK version 1.07 [18]. The significant associations were defined by genomewide significance level p-values (<5 × 10-8) and genome-wide suggestive p-values (5 × 10-8 ≤ p < 1 × 10-5).
The LD between the previously reported GWAS SNPs and the SNPs of the current GWAS was investigated with SNAP web-based software ( and GWAS catalog ( For example, we entered our top significant SNPs in the SNAP input panel and found high LD SNPs with r2 > 0.9 and D' = 1 around 1 Mbp. The high-LD SNPs were investigated in the GWAS catalog ( as to whether they were previously reported or not.
To maximize the candidate risk factors of METS, we selected additional functional SNPs in the eQTLs or nsSNP loci (5 × 10-5 ≤ p < 1 × 10-4). Among the Affymetrix 5.0 SNPs, we investigated the eQTL SNPs from regulomeDB ( and the nsSNPs from BioMart (
The genetic variances of the top association SNPs were estimated by GCTA v1.24 [16], which is a tool for estimating the proportion [V(G)/V(P)] of phenotypic variance [V(P)] explained by SNPs [V(G)] for complex traits. We selected the SNP sets based on the GWAS p-values from 100 to 1,000 SNPs with 10-SNP intervals and from 1,000 to 5,000 SNPs with 1,000-SNP intervals. We decided the number of SNPs in the maximum set based on the genetic variance approximated the METS heritability reported from the Korean twin study [5]. The pair-wise genetic relationships were estimated using the make-grm option, and the proportion of the phenotypic variance explained by the associated SNPs was estimated by the grm-test option with the restricted maximum likelihood [11].

In silico analysis

The functional relevance of the associated SNP sites was analyzed by overlapping the gene-coding sequence or the Encyclopedia of DNA Element (ENCODE) regulatory element positions in the University of California Santa Cruz (UCSC) genome browser ( Thereafter, regulomeDB ( was utilized to extract eQTL information. In addition, Pathway Studio version 9.0 software (Ariadne Genomics, Rockville, MD, USA) was utilized to analyze the functional interactions and possible pathways among genes/proteins in our data. It provides an interpretation of the biological implications from gene/protein expression data, the establishment of molecular pathways, and an identification of protein interaction maps and their association to cellular process [19].

Results and Discussion

Genome-wide association study

Table 1 describes the clinical characteristics of Ansung and Ansan regarding the METS criteria: BMI, WC, SBP, DBP, GLU0, HDL, and TG. Based on the NCEP-ATPIII METS criteria for Asians [14], 2,657 KARE subjects were included in the METS cases. The SNPs showing strong and moderate evidence of association (p < 1 × 10-5) are indicated in the Manhattan plot of the GWAS (Fig. 1). In addition to these SNPs, we identified several functional SNPs with suggestive evidence of association (5 × 10-8 ≤ p). In this study, we selected 12 SNPs, of which 2 had genome-wide significant associations (p < 5 × 10-8), 8 had suggestive associations (5 × 10-8 ≤ p < 1 × 10-5), and 2 had functional variants (1 × 10-5 ≤ p < 1 × 10-4) (Table 2) [8, 20, 21, 22]. The top SNP (rs11216126) and 3 suggestive SNPs (rs6589566, rs174 82753, and rs10503669) were previously reported as being associated with METS-related traits, such as serum cholesterol levels or TG levels [8, 20, 21].
LD analysis using 10 SNPs was conducted with the previously reported GWAS SNPs. As a result, 5 SNPs had strong LD with the 15 highly linked GWAS SNPs (Table 3) [23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34]. Among the 6 remaining SNPs associated with METS in our GWAS results, 2 SNPs (rs180349 and rs17410962) showed high LD with the previously reported SNPs (r2 > 0.9 and D' = 1) even though the 2 SNPs have not been reported regarding metabolic traits.
Therefore, we discovered 10 significant or suggestive associated SNPs in the METS GWAS, but 6 of them were already reported or linked to the reported SNPs. The remaining 4 suggestive signals and 2 functional variants have been first reported in the current study, and a replication study should be performed in other independent populations.

In silico annotation of the linked genes and functional relevance

The 10 associated SNPs and the LD SNPs were located in six functional gene regions, and one SNP was located in the intergenic region. The top signals were located downstream of a functional spliceosome-associated protein, named BUD13, a homolog of yeast (BUD13) gene chromosome 11 and near the BUD13 gene. BUD13 has been reported to be associated with lipid, metabolic syndrome X [23], TG [32], and metabolic traits in East Asians [8], demonstrating that it is putatively functionally associated with METS in the Korean population (Supplementary Table 1).
The second significant SNP was rs6589566, which has 6 high-LD SNPs. Notably, in silico annotation of the SNP's function showed that rs651821 was located in the 5' untranslated region (UTR) of the APOA5 gene, and also, the SNP was reported as an eQTL of the transgelin (TAGLN) gene (Table 4). The results indicate that the remaining SNPs are surrogate markers of rs6589566. Among them, rs651821 and rs964184 are associated with TG level, as one component of METS evaluation, in Chinese populations [26] and in Mexicans [35]. Both SNPs exhibit eQTL of the TAGLN gene. TAGLN has been documented as a repressive regulator of matrix metalloproteinase 9 (MMP9) gene expression [36] and is considered a putative tumor suppressor due to suppression of MMP-9, which harbors tumor metastatic properties [37]. However, MMP-9 is also involved in the progression of METS via chymase activity [38] and has been suggested to be used a diagnostic marker of METS [39]. Thus, it can be explained that the functional eQTL TAGLN of rs651821 and rs964184 could be a novel marker for the evaluation of METS in terms of strong regulation of MMP-9.
The third most significant signals were located in the lipoprotein lipase (LPL) gene region. Three SNPs (rs10503669, rs17482753, and rs17410962) located in chr 8 were eQTL that contributed to LPL expression in monocytes. LPL is a critical protein of lipid metabolism and is significantly associated with METS in Asian Indians [40], indicating that the functional eQTL-SNP of LPL expression could be a marker for the evaluation of METS in Korean populations. Those three SNPs were in strong LD with rs328, which is a stop-gain mutation of the LPL coding sequence [41] (Supplementary Table 1). Although the remaining 14 SNPs were non-eQTL-SNPs, those SNPs have been reported as being in association with HDL cholesterol, low-density lipoprotein cholesterol, TG, and obesity, indicating that they are putative candidate markers for the evaluation of METS.
Although the remaining 6 SNPs and their nearest genes have not been functionally studied regarding METS-associated traits, further studies are required to elucidate for their role in METS.

Pathway network analysis

The results of the V(G)/V(P) for 100 to 5,000 SNPs were plotted in Fig. 2. When we used 5,000 SNPs, V(G)/V(P) approximated 50%, and we extracted functional SNPs, such as eQTLs and nsSNPs, from the 5,000 SNPs. We could extract 159 eQTLs and 18 nsSNPs among the 5,000 SNPs (Supplementary Table 2). Notably, 6 eQTL genes and 2 nsSNP genes consisted of LPL and the apolipoprotein A-V (APOA5) pathway through the interaction of a number of mediated genes (Table 4). Among them, muscle creatinine kinase (CKM) has been documented to regulate LPL activity [42], demonstrating that it is putatively associated with METS. Those additionally identified genes might be candidate targets of METS for further study (Fig. 3).
eQTLs and nsSNPs provide insights into the regulation of transcription and aid in the interpretation of GWASs [22]. Most of the eQTL resources are available in online databases, such as RegulomeDB (, including several published resources in various cell types, such as monocytes [43], human brain [44], lymphoblastoid cell lines [45, 46], and human liver [47]. Probably, RegulomeDB is one of the most useful eQTL databases, because it contains rich information about the products of the ENCODE project, such as transcription factor binding sites, chromatin structure, histone modification, and eQTLs. Our pathway results suggest an internal mechanism of LPL, APOA5, and muscarinic acetylcholine receptor M2 (CHRM2) functions in METS. Therefore, we suggest that 6 eQTLs and 2 nsSNP loci might be additional targets for further association studies and functional analysis.
Conclusively, our approach using the conventional GWAS, reconsidering functional variants and the pathway-based interpretation, suggests a useful method to understand the GWAS results of complex traits and can be expanded in other GWASs.


This work was supported by grants from the Korea Centers for Disease Control and Prevention (KCDC), Republic of Korea (4845-301, 4851-302, 4851-307). This study was also supported by an internal project, "Construction of databases and an analysis system for Korean reference genomes for disease researches" (2013-NG72001-00), of the Korea National Institute of Health, KCDC.


This is 2014 KNIH KARE best paper awarded.

Supplementary materials

Supplementary data including two tables and one figure can be found with this article online at

Supplementary Table 1

In silico annotation of the associated SNPs with METS

Supplementary Table 2

The list of functional SNPs among the top 5,000 SNPs associated with METS

Supplementary Fig. 1

Overall study design to understand the metabolic syndrome (METS) risk genetic factors in Korean. SNP, single nucleotide polymorphism.


1. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet 2005;366:1059–1062. PMID: 16182882.
crossref pmid
2. Haffner S, Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation 2003;108:1541–1545. PMID: 14517149.
crossref pmid
3. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004;33:351–375. PMID: 15158523.
crossref pmid
4. Song J, Kim E, Shin C, Kim SS, Lee HK, Jung M, et al. Prevalence of the metabolic syndrome among South Korean adults: the Ansan study. Diabet Med 2004;21:1154–1155. PMID: 15384966.
crossref pmid
5. Sung J, Lee K, Song YM. Heritabilities of the metabolic syndrome phenotypes and related factors in Korean twins. J Clin Endocrinol Metab 2009;94:4946–4952. PMID: 19837915.
crossref pmid
6. Pennisi E. Breakthrough of the year. Human genetic variation. Science 2007;318:1842–1843. PMID: 18096770.
crossref pmid
7. Naidoo N, Pawitan Y, Soong R, Cooper DN, Ku CS. Human genetics and genomics a decade after the release of the draft sequence of the human genome. Hum Genomics 2011;5:577–622. PMID: 22155605.
crossref pmid pmc
8. Kim YJ, Go MJ, Hu C, Hong CB, Kim YK, Lee JY, et al. Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits. Nat Genet 2011;43:990–995. PMID: 21909109.
crossref pmid
9. Eichler EE, Flint J, Gibson G, Kong A, Leal SM, Moore JH, et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet 2010;11:446–450. PMID: 20479774.
crossref pmid pmc
10. Fransen K, Visschedijk MC, van Sommeren S, Fu JY, Franke L, Festen EA, et al. Analysis of SNPs with an effect on gene expression identifies UBE2L3 and BCL3 as potential new risk genes for Crohn's disease. Hum Mol Genet 2010;19:3482–3488. PMID: 20601676.
crossref pmid
11. Yang J, Benyamin B, McEvoy BP, Gordon S, Henders AK, Nyholt DR, et al. Common SNPs explain a large proportion of the heritability for human height. Nat Genet 2010;42:565–569. PMID: 20562875.
crossref pmid pmc
12. Ko KP, Min H, Ahn Y, Park SJ, Kim CS, Park JK, et al. A prospective study investigating the association between environmental tobacco smoke exposure and the incidence of type 2 diabetes in never smokers. Ann Epidemiol 2011;21:42–47. PMID: 21130368.
crossref pmid
13. Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH, Ban HJ, et al. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet 2009;41:527–534. PMID: 19396169.
crossref pmid
14. Ahn Y, Park SJ, Kwack HK, Kim MK, Ko KP, Kim SS. Rice-eating pattern and the risk of metabolic syndrome especially waist circumference in Korean Genome and Epidemiology Study (KoGES). BMC Public Health 2013;13:61. PMID: 23339671.
crossref pmid pmc pdf
15. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–3421. PMID: 12485966.
crossref pmid
16. Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet 2011;88:76–82. PMID: 21167468.
crossref pmid pmc
17. Rabbee N, Speed TP. A genotype calling algorithm for affymetrix SNP arrays. Bioinformatics 2006;22:7–12. PMID: 16267090.
crossref pmid
18. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559–575. PMID: 17701901.
crossref pmid pmc
19. Nikitin A, Egorov S, Daraselia N, Mazo I. Pathway studio: the analysis and navigation of molecular networks. Bioinformatics 2003;19:2155–2157. PMID: 14594725.
crossref pmid
20. Wallace C, Newhouse SJ, Braund P, Zhang F, Tobin M, Falchi M, et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet 2008;82:139–149. PMID: 18179892.
crossref pmid pmc
21. Heid IM, Boes E, Müller M, Kollerits B, Lamina C, Coassin S, et al. Genome-wide association analysis of high-density lipoprotein cholesterol in the population-based KORA study sheds new light on intergenic regions. Circ Cardiovasc Genet 2008;1:10–20. PMID: 20031538.
crossref pmid
22. Liang L, Morar N, Dixon AL, Lathrop GM, Abecasis GR, Moffatt MF, et al. A cross-platform analysis of 14,177 expression quantitative trait loci derived from lymphoblastoid cell lines. Genome Res 2013;23:716–726. PMID: 23345460.
crossref pmid pmc
23. Kraja AT, Vaidya D, Pankow JS, Goodarzi MO, Assimes TL, Kullo IJ, et al. A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium. Diabetes 2011;60:1329–1339. PMID: 21386085.
crossref pmid pmc
24. Kooner JS, Chambers JC, Aguilar-Salinas CA, Hinds DA, Hyde CL, Warnes GR, et al. Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides. Nat Genet 2008;40:149–151. PMID: 18193046.
crossref pmid
25. Comuzzie AG, Cole SA, Laston SL, Voruganti VS, Haack K, Gibbs RA, et al. Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population. PLoS One 2012;7:e51954. PMID: 23251661.
crossref pmid pmc
26. Tan A, Sun J, Xia N, Qin X, Hu Y, Zhang S, et al. A genome-wide association and gene-environment interaction study for serum triglycerides levels in a healthy Chinese male population. Hum Mol Genet 2012;21:1658–1664. PMID: 22171074.
crossref pmid
27. Coram MA, Duan Q, Hoffmann TJ, Thornton T, Knowles JW, Johnson NA, et al. Genome-wide characterization of shared and distinct genetic components that influence blood lipid levels in ethnically diverse human populations. Am J Hum Genet 2013;92:904–916. PMID: 23726366.
crossref pmid pmc
28. Sabatti C, Service SK, Hartikainen AL, Pouta A, Ripatti S, Brodsky J, et al. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 2009;41:35–46. PMID: 19060910.
crossref pmid pmc
29. Chasman DI, Paré G, Mora S, Hopewell JC, Peloso G, Clarke R, et al. Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. PLoS Genet 2009;5:e1000730. PMID: 19936222.
crossref pmid pmc
30. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010;466:707–713. PMID: 20686565.
crossref pmid pmc
31. Middelberg RP, Ferreira MA, Henders AK, Heath AC, Madden PA, Montgomery GW, et al. Genetic variants in LPL, OASL and TOMM40/APOE-C1-C2-C4 genes are associated with multiple cardiovascular-related traits. BMC Med Genet 2011;12:123. PMID: 21943158.
crossref pmid pmc
32. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 2008;40:189–197. PMID: 18193044.
crossref pmid pmc
33. Johansen CT, Wang J, Lanktree MB, Cao H, McIntyre AD, Ban MR, et al. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet 2010;42:684–687. PMID: 20657596.
crossref pmid pmc
34. Kristiansson K, Perola M, Tikkanen E, Kettunen J, Surakka I, Havulinna AS, et al. Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits. Circ Cardiovasc Genet 2012;5:242–249. PMID: 22399527.
crossref pmid pmc
35. Weissglas-Volkov D, Aguilar-Salinas CA, Nikkola E, Deere KA, Cruz-Bautista I, Arellano-Campos O, et al. Genomic study in Mexicans identifies a new locus for triglycerides and refines European lipid loci. J Med Genet 2013;50:298–308. PMID: 23505323.
crossref pmid pmc
36. Nair RR, Solway J, Boyd DD. Expression cloning identifies transgelin (SM22) as a novel repressor of 92-kDa type IV collagenase (MMP-9) expression. J Biol Chem 2006;281:26424–26436. PMID: 16835221.
crossref pmid
37. Assinder SJ, Stanton JA, Prasad PD. Transgelin: an actin-binding protein and tumour suppressor. Int J Biochem Cell Biol 2009;41:482–486. PMID: 18378184.
crossref pmid
38. Takai S, Jin D, Miyazaki M. Chymase as an important target for preventing complications of metabolic syndrome. Curr Med Chem 2010;17:3223–3229. PMID: 20666722.
crossref pmid
39. Cicero AF, Derosa G, Manca M, Bove M, Borghi C, Gaddi AV. Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease. Endothelium 2007;14:193–198. PMID: 17922335.
crossref pmid
40. Ranjith N, Pegoraro RJ, Rom L. Lipid profiles and associated gene polymorphisms in young Asian Indian patients with acute myocardial infarction and the metabolic syndrome. Metab Syndr Relat Disord 2009;7:571–578. PMID: 19642912.
crossref pmid
41. Deo RC, Reich D, Tandon A, Akylbekova E, Patterson N, Waliszewska A, et al. Genetic differences between the determinants of lipid profile phenotypes in African and European Americans: the Jackson Heart Study. PLoS Genet 2009;5:e1000342. PMID: 19148283.
crossref pmid pmc
42. Sattler W, Levak-Frank S, Radner H, Kostner GM, Zechner R. Muscle-specific overexpression of lipoprotein lipase in transgenic mice results in increased alpha-tocopherol levels in skeletal muscle. Biochem J 1996;318(Pt 1):15–19. PMID: 8761445.
crossref pmid pmc
43. Zeller T, Wild P, Szymczak S, Rotival M, Schillert A, Castagne R, et al. Genetics and beyond: the transcriptome of human monocytes and disease susceptibility. PLoS One 2010;5:e10693. PMID: 20502693.
crossref pmid pmc
44. Gibbs JR, van der Brug MP, Hernandez DG, Traynor BJ, Nalls MA, Lai SL, et al. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet 2010;6:e1000952. PMID: 20485568.
crossref pmid pmc
45. Veyrieras JB, Kudaravalli S, Kim SY, Dermitzakis ET, Gilad Y, Stephens M, et al. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet 2008;4:e1000214. PMID: 18846210.
crossref pmid pmc
46. Montgomery SB, Sammeth M, Gutierrez-Arcelus M, Lach RP, Ingle C, Nisbett J, et al. Transcriptome genetics using second generation sequencing in a Caucasian population. Nature 2010;464:773–777. PMID: 20220756.
crossref pmid pmc
47. Schadt EE, Molony C, Chudin E, Hao K, Yang X, Lum PY, et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol 2008;6:e107. PMID: 18462017.
crossref pmid pmc
Fig. 1
Manhattan plot of metabolic syndrome genome-wide association study -log10(p-values). All black and grey circles indicate the individual single nucleotide polymorphisms (SNPs). The red horizontal line is the genome-wide significance level (p = 5 × 10-8), and the blue horizontal line is the genome-wide suggestive level (5 × 10-8 ≤ p < 1 × 10-5). The top significant SNPs are depicted on the right site of the SNP.
Fig. 2
The proportion of phenotypic variance [V(P)] explained by the genotypic variance [V(G)]. The horizontal axis denotes the number of single nucleotide polymorphisms (SNPs). Approximately 50% of phenotypic variance could be explained by the top 5,000 SNPs.
Fig. 3
Illustration of molecular pathway for significantly associated single nucleotide polymorphism (SNP) loci in the metabolic syndrome genome-wide association study (GWAS). The molecules depicted by the significant GWAS loci (reds), functional SNPs (expression quantitative trait loci or nonsynonymous SNPs) loci (green), and the other intermediate molecules (yellow) are illustrated on the cell organelles.
Table 1.
Clinical characteristics of metabolic syndrome-related traits
Total Anseong Ansan p-value
No. of individuals 8,842 4,205 4,637
Gender (men:women) 4,183 (47.3):4,659 (52.7) 1,809 (43.0):2,396 (57.0) 2,374 (51.2):2,263 (48.8)
Age (y) 52.2 ± 8.9 55.7 ± 8.7 49.1 ± 7.9 <0.01
Height (cm) 160.0 ± 8.7 158.3 ± 8.6 161.6 ± 8.4 <0.01
Body mass index (kg/m2) 24.6 ± 3.1 24.5 ± 3.3 24.7 ± 3.0 <0.01
Fasting glucose (mg/dL) 87.7 ± 21.9 85.9 ± 18.3 89.1 ± 24.4 <0.01
DBP (mm Hg) 80.3 ± 11.5 82.5 ± 10.9 78.2 ± 11.6 <0.01
SBP (mm Hg) 121.7 ± 18.6 126.6 ± 18.8 117.2 ± 17.3 <0.01
Waist circumference (cm) 82.7 ± 8.8 84.6 ± 8.7 81.0 ± 8.5 <0.01
HDL cholesterol (mg/dL) 44.7 ± 10.1 44.6 ± 10.3 44.7 ± 9.9 0.62
TG (mg/dL) 162.9 ± 105.7 165.0 ± 107.2 161.0 ± 104.3 0.07
 METs case/control 2,657/5,917 1,490/2,454 1,167/3,463 <0.01

Values are presented as number (%) or mean ± SD.

DBP, diastolic blood pressure; SBP, systolic blood pressure; HDL, high-density lipoprotein; TG, triglyceride; MET, metabolic syndrome.

a METs status: three or more of the component as follows: waist circumference (≥90 cm for men, ≥80 cm for women), HDL (<40 mg/dL for men, <50 mg/dL for women), TG (≥150 mg/dL), blood pressure (SBP ≥ 130 mm Hg or DBP ≥ 85 mm Hg), fasting glucose (≥100 mg/dL).

Table 2.
Genome-wide association results for METs case-control study in the Korean population
SNP ID CHR BP Effect allele/other EAF Previous GWAS reports for the METS SNPs OR 95% Confidence interval
Lower Upper
Genome-wide significant levels (p < 5 × 10–8)
 rs11216126 11 116122450 A/C 0.798 Decrease HDL [8] 1.33 1.21 1.46 7.15 × 10–9
 rs180349 11 116117037 A/T 0.227 - 1.28 1.17 1.4 4.12 × 10–8
Genome-wide suggestive levels (5 × 10–8 ≤ p < 1 × 10–5)
 rs6589566 11 116157633 C/T 0.218 Increase triglycerides [20] 1.27 1.16 1.39 2.26 × 10–7
 rs17410962 8 19892360 G/A 0.876 - 1.34 1.2 1.5 5.75 × 10–7
 rs17482753 8 19876926 G/T 0.876 Increase triglycerides [21] 1.34 1.2 1.51 6.34 × 10–7
 rs10503669 8 19891970 C/A 0.879 Increase triglycerides and decrease HDL cholesterol [8] 1.34 1.2 1.51 7.25 × 10–7
 rs2350786 7 136327110 A/G 0.637 - 1.21 1.12 1.31 1.33 × 10–6
 rs486394 11 116031532 C/A 0.122 - 1.32 1.18 1.47 1.64 × 10–6
 rs1668775 10 36639540 T/C 0.211 - 1.24 1.14 1.36 2.07 × 10–6
 rs605257 9 10300942 T/A 0.770 - 1.22 1.12 1.33 6.48 × 10–6
Expression quantitative trait loci (1 × 10–5 ≤ p < 1 × 10–4)
 rs1996794 11 9779172 C/A 0.411 eQTL of SWAP70 [22] 1.17 1.09 1.27 2.73 × 10–5
 rs1032550 11 9769884 C/T 0.410 eQTL of SWAP70 [22] 1.16 1.08 1.25 2.73 × 10–5

METS, metabolic syndrome; SNP, single nucleotide polymorphism; CHR, chromosome; BP, base pair based on the human reference genome (hg18); EAF, effect allele frequency; GWAS, genome-wide association study; OR, odds ratio; HDL, high-density lipoprotein; eQTL, expression quantitative trait loci.

Table 3.
Reported GWAS SNPs that show LD with our study SNPs
LD states
Reported traits References
This study Reported GWAS r2 D'
Genome-wide significant levels (p < 5 × 10–8)
rs180349 rs10790162 0.912 0.955 HDL cholesterol and triglycerides [23]
rs1558861 0.956 1 Triglycerides [24]
Genome-wide suggestive levels (5 × 10–8 ≤ p < 1 × 10–5)
 rs6589566 rs10790162 0.912 0.955 HDL cholesterol and triglycerides [23]
rs2075290 0.956 1 HDL cholesterol and triglycerides [23]
rs2160669 1 1 Obesity-related traits [25]
rs2266788 1 1 HDL cholesterol and triglycerides [23]
rs651821 1 1 Triglycerides [26]
rs964184 0.957 1 HDL cholesterol [27]
rs17410962 rs10096633 1 1 Metabolic traits [28]
 rs17482753 rs1059611 0.925 1 Lipid metabolism phenotypes [29]
 rs10503669 rs12678919 1 1 HDL cholesterol [30]
rs17091905 1 1 Cardiovascular disease risk factors [31]
rs328 1 1 Triglycerides [32]
rs7016880 0.925 1 Hypertriglyceridemia [33]
rs7841189 1 1 Metabolic syndrome [34]

The underlined SNPs indicate that the lead SNPs have not been reported, but there were highly linked GWAS SNPs.

GWAS, genome-wide association study; SNP, single nucleotide polymorphism; LD, linkage disequilibrium; HDL, high-density lipoprotein.

Table 4.
GWAS results of eQTLs and nonsynonymous SNPs consisting of the LPL and APOA5 pathways
CHR SNP BP A1 MAF 95% Confidence interval
p-value Gene Amino acid substitution Description
OR Lower Upper
eQTLs among the METS GWAS
21 rs2236472 45727840 A 0.124 0.83 0.74 0.93 1.6E-03 COL18A1 - Collagen, type XVIII, alpha 1
6 rs4713671 33807877 A 0.191 1.13 1.04 1.24 7.2E-03 ITPR3 - Inositol 1,4,5-triphosphate receptor, type 3
19 rs344802 50496147 T 0.204 0.89 0.81 0.97 1.0E-02 CKM - Creatine kinase, muscle
18 rs4998986 55282713 A 0.369 0.88 0.82 0.96 2.0E-03 MALT1 - Mucosa-associated lymphoid tissue lymphoma translocation gene 1
18 rs4998985 55282774 A 0.298 0.86 0.79 0.93 3.3E-04 MALT1 - Mucosa-associated lymphoid tissue lymphoma translocation gene 1
10 rs871026 1.31E+08 G 0.384 0.88 0.81 0.95 9.8E-04 MGMT - O-6-Methylguanine-DNA methyltransferase
Nonsynonymous substitution SNPs among the METS GWAS
9 rs2296871 1.34E+08 A 0.263 0.89 0.82 0.97 8.6E-03 MAPK7 E79G Mitogen-activated protein kinase 7
1 rs11802875 1.62E+08 A 0.0333 1.35 1.10 1.65 4.0E-03 NUF2 S229L NUF2, NDC80 kinetochore complex component, homolog (Saccharomyces cerevisiae)

GWAS, genome-wide association study; eQTL, expression quantitative trait loci; SNP, single-nucleotide polymorphism; LPL, lipoprotein lipase; APOA5, apolipoprotein A-V; CHR, chromosome; BP, base pair; A1, minor allele; MAF, minor allele frequency; OR, odds ratio; METS, metabolic syndrome.


Browse all articles >

Editorial Office
Room No. 806, 193 Mallijae-ro, Jung-gu, Seoul 04501, Korea
Tel: +82-2-558-9394    Fax: +82-2-558-9434    E-mail:                

Copyright © 2023 by Korea Genome Organization.

Developed in M2PI

Close layer
prev next